Liven Pharmaceuticals Limited (PSX:LIVEN)
66.19
-0.79 (-1.18%)
At close: Aug 1, 2025
Verve Therapeutics Market Cap
Liven Pharmaceuticals has a market cap or net worth of 6.16 billion as of August 1, 2025. Its market cap has increased by 4,223.05% in one year.
Market Cap
6.16B
Enterprise Value
6.20B
Revenue
120.79M
Ranking
n/a
PE Ratio
34.80
Stock Price
$66.19
Market Cap Chart
Since November 2, 2004, Liven Pharmaceuticals's market cap has increased from 78.80M to 6.16B, an increase of 7,714.75%. That is a compound annual growth rate of 23.36%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 6.16B | 237.42% |
Dec 31, 2024 | 1.83B | 840.88% |
Dec 26, 2023 | 193.98M | -25.16% |
Dec 30, 2021 | 259.20M | 49.30% |
Dec 31, 2020 | 173.61M | 36.64% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Oil and Gas Development Company | 1,914.89B |
Oil and Gas Development Company | 1,102.37B |
United Bank | 922.97B |
Mari Energies | 745.96B |
Fauji Fertilizer Company | 651.21B |
Meezan Bank | 649.01B |
Lucky Cement | 522.93B |
Pakistan Petroleum | 462.05B |